Vanderbilt Cancer Center — Nashville, Tennessee

Vanderbilt Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232-6838.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt Cancer Center has participated in 54 clinical trials with 3 currently active.

Therapeutic areas: Leukemia, Myelodysplastic Syndromes, Metastatic Cancer.

Sponsors: Children's Oncology Group, Pharmacyclics LLC., Eastern Cooperative Oncology Group.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Cancer Center?

Vanderbilt Cancer Center has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Cancer Center conducted?

Vanderbilt Cancer Center has 54 clinical trials on record, with 3 currently active. Their work covers Leukemia, Myelodysplastic Syndromes, Metastatic Cancer.

Is Vanderbilt Cancer Center accredited by Crixeo Health?

Vanderbilt Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.